University of Malaya
2 clinical trials · 2 recruiting · OTHER
Trials by University of Malaya
RECRUITINGPhase 2NCT05286619
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head...
This is an open-label, single-arm, Phase 2 study of pembrolizumab plus platinum and gemcitabine (PG) in subjects with recurrent or metastatic head and neck cancer squamous cell...
Sponsor: University of MalayaEnrolling: 631 location
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
RECRUITINGNCT07069387
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
The gold standard for tuberculosis (TB) treatment support requires directly observed therapy (DOT), which means a trained health worker observes the patient swallow each dose of...
Sponsor: University of MalayaEnrolling: 1601 location
Tuberculosis (TB)